[Clinico-functional evaluation of a new potassium-sparing diuretic: amiloride].
作者信息
Boschetti E, Dottorini M, Bentivoglio M, Losito A, Grassi V, Muiesan G
出版信息
Clin Ter. 1977 Mar 31;80(6):530-6.
PMID:862353
Abstract
摘要
相似文献
1
[Clinico-functional evaluation of a new potassium-sparing diuretic: amiloride].
Clin Ter. 1977 Mar 31;80(6):530-6.
2
[Clinical and pharmacodynamic study of a new potassium-sparing diuretic: amiloride hydrochloride].一种新型保钾利尿剂：盐酸阿米洛利的临床及药效学研究
J Med Lyon. 1972 Sep 20;53(233):1237-70.
3
[Treatment of the hypertensive patient. Value of Amiloride during saldiuretic treatment].[高血压患者的治疗。阿米洛利在保钾利尿治疗中的价值]
Nouv Presse Med. 1972 Sep 16;1(32):2121-2.
4
The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.新型保钾利尿剂氨氯吡咪和转换酶抑制剂MK-421在预防原发性和继发性醛固酮增多症相关低钾血症中的治疗应用。
Clin Exp Hypertens A. 1983;5(6):779-801. doi: 10.3109/10641968309081808.
5
[Effect of amiloride on potassium loss induced by hydrochlorothiazide].
Nouv Presse Med. 1974 Sep 21;3(31):1953-4.
6
Selected mechanisms of diuretic-induced electrolyte changes.利尿剂引起电解质变化的选定机制。
Am J Cardiol. 1986 Jul 31;58(2):1A-4A. doi: 10.1016/0002-9149(86)90874-x.
7
Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure.布美他尼，一种新型强效利尿剂。充血性心力衰竭的临床评估。
Acta Med Scand. 1973 Jan-Feb;193(1-2):119-31.
8
Amiloride in primary hyperaldosteronism.氨氯吡咪在原发性醛固酮增多症中的应用
Clin Pharmacol Ther. 1982 Jan;31(1):56-61. doi: 10.1038/clpt.1982.9.
9
Diuretic effect of butoxymethylen furosemide (FFBU) in healthy subjects: a preliminary study.丁氧亚甲基速尿（FFBU）对健康受试者的利尿作用：一项初步研究。
Curr Ther Res Clin Exp. 1973 Oct;15(10):713-26.
10
[Esmaloride--a new potassium neutral diuretic combination. Clinical pharmacologic properties].埃斯马洛利德——一种新型钾中性利尿合剂。临床药理学特性
Fortschr Med. 1985 Feb 14;103(6):125-9.
Zotero 插件